SCHEMBL2945910

SCHEMBL2945910

Cc1cc(Br)ccc1-c1ccc(Br)cc1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S100A4 P26447 1/20 0.46
ALDH1A1 P00352 3/20 0.43
MAPK1 P28482 1/20 0.42
PTPRC P08575 1/20 0.39
CYP2A6 P11509 2/20 0.39
ESR1 P03372 2/20 0.38
ESR2 Q92731 2/20 0.38
BCL2 P10415 1/20 0.38
MCL1 Q07820 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA4 P22748 1/20 0.38
CA7 P43166 1/20 0.38
CA9 Q16790 1/20 0.38
SIGMAR1 Q99720 2/20 0.37
PYCR1 P32322 1/20 0.37
LMNA P02545 1/20 0.37
RAPGEF4 Q8WZA2 1/20 0.37
FFAR1 O14842 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18268298 0.95 S100A4 (0.42) S100A4ALDH1A1MAPK1PTPRCCYP2A6
SCHEMBL12476663 0.88 PTPRC (0.47) S100A4ALDH1A1MAPK1PTPRCCYP2A6
SCHEMBL30057174 0.86 ALDH1A1 (0.50) S100A4ALDH1A1MAPK1LMNANPSR1
SCHEMBL12476326 0.86 ALDH1A1 (0.50) S100A4ALDH1A1MAPK1LMNANPSR1
SCHEMBL12476819 0.86 S100A4 (0.37) S100A4ALDH1A1MAPK1PTPRCESR1
SCHEMBL30414134 0.85 ESR2 (0.42) S100A4ALDH1A1MAPK1CYP2A6ESR1
SCHEMBL679627 0.85 ESR2 (0.42) S100A4ALDH1A1MAPK1CYP2A6ESR1
SCHEMBL6519997 0.83 ALDH1A1 (0.42) S100A4ALDH1A1MAPK1CYP2A6ESR1
SCHEMBL18323225 0.82 S100A4 (0.39) S100A4PTPRCBCL2MCL1CA1
SCHEMBL177529 0.81 ESR2 (0.59) ALDH1A1MAPK1PTPRCCYP2A6ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260104614-A1 ELECTROCHROMIC MEDIUM COMPOSITION AND PREPARATION METHOD THEREOF, AND ELECTROCHROMIC DEVICE VALLIGHT OPTICS TECH NINGBO CO LTD (CN) 2026-04-16 US disclosed
CN-118931523-B Electrochromic medium composition, preparation method thereof and electrochromic device 宁波华瓴光学技术有限公司 2025-04-15 CN disclosed
EP-3596065-B1 COMPOUNDS WITH ARYLAMINE STRUCTURES MERCK PATENT GMBH (DE) 2024-12-25 EP disclosed
CN-118931523-A Electrochromic medium composition, preparation method thereof and electrochromic device 宁波华瓴光学技术有限公司 2024-11-12 CN disclosed
CN-118027847-A Application of compound as ultraviolet light conversion agent 江苏绿人半导体有限公司 2024-05-14 CN disclosed
WO-2023247416-A1 TETRAARYLBENZIDINE TYPE COMPOUNDS AND THEIR USE IN ORGANIC ELECTRONICS DOTTIKON ES HOLDING AG (CH) 2023-12-28 WO disclosed
US-11702542-B2 Composition including polymer, interlayer prepared from the composition, and device comprising the same SAMSUNG DISPLAY CO., LTD. (KR) 2023-07-18 US disclosed
US-11702542-B2 Composition including polymer, interlayer prepared from the composition, and device comprising the same SAMSUNG DISPLAY CO., LTD. (KR) 2023-07-18 US disclosed
US-11572378-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-07 US disclosed
CN-115417773-A Dendritic structure compound and compound thereof, and organic electroluminescent device 中国科学院长春应用化学研究所 2022-12-02 CN disclosed
US-7898163-B2 (Partially) conjugated polymer, process for its preparation and use in electroluminescent devices CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) 2011-03-01 US disclosed
US-7898163-B2 (Partially) conjugated polymer, process for its preparation and use in electroluminescent devices CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) 2011-03-01 US disclosed
US-7759855-B2 Organic electroluminescent element and display employing the same KONICA MINOLTA HOLDINGS, INC. (JP) 2010-07-20 US disclosed
EP-1370599-B1 (PARTIALLY) CONJUGATED POLYMER, PROCESS FOR ITS PREPARATION AND USE IN ELECTROLUMINESCENT DEVICES CAMBRIDGE DISPLAY TECH LTD (GB) 2007-08-29 EP disclosed
US-20070077450-A1 Conjugated compounds containing triarylamine structural elements, and their use LUMINESCENCE TECHNOLOGY CORP. (TW) 2007-04-05 US disclosed
US-20070077450-A1 Conjugated compounds containing triarylamine structural elements, and their use LUMINESCENCE TECHNOLOGY CORP. (TW) 2007-04-05 US disclosed
US-20070034832-A1 (Partially) conjugated polymer, process for its preparation and use in electroluminescent devices CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) 2007-02-15 US disclosed
US-20070034832-A1 (Partially) conjugated polymer, process for its preparation and use in electroluminescent devices CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) 2007-02-15 US disclosed
US-20040178721-A1 Organic electroluminescent element and display employing the same UDC IRELAND LIMITED (IE) 2004-09-16 US disclosed
EP-1457543-A1 Organic electroluminescent element and display employing the same KONICA MINOLTA HOLDINGS, INC. (JP) 2004-09-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11572378-B2 Heterocyclic compound and organic light-emitting device including the same CYP1A1, CRY1, CYP1B1 S100A4 2399/4885ALDH1A1 4/4885MAPK1 756/4885
US-20260104614-A1 ELECTROCHROMIC MEDIUM COMPOSITION AND PREPARATION METHOD THEREOF, AND ELECTROCHROMIC DEVICE CHRM1, C5, CHRM2 S100A4 1278/4885ALDH1A1 1028/4885MAPK1 603/4885
US-20070077450-A1 Conjugated compounds containing triarylamine structural elements, and their use TIMM9, DCX, INMT S100A4 1291/4885ALDH1A1 1442/4885MAPK1 2953/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.